PTCH1 and neoplasm: BCC is characterized by dysregulated activation of the Hedgehog signaling pathway due to mutations in PTCH1 or SMO genes, leading to uncontrolled cell proliferation and tumor formation, making the pathway a target for BCC treatments [2].